Search
for
Sort by
Research 61–90 of 1000+
- A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
- OTITIS EXTERNA AND OTITIS MEDIA IN CATS IN ASSIUT: A RETROSPECTIVE STUDY OF PRESENTING SIGNS, CAUSES, DIAGNOSIS AND TREATMENT
- Effect of Patient Age on Platelet-Rich Plasma (PRP) and Fibrin Treatments for Skin Density and Thickness: A Single-Center Ultrasound Study
- The effect of plasma rich in growth factors combined with follicular unit extraction surgery for the treatment of hair loss: A pilot study
- Mechanism of action of NLRP3 protein macromolecule based on electrochemical sensors in the treatment of alopecia areata in mice: The role of Ritlecitinib in AA mice through NLRP3
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- Effectiveness of QR678 and QR678 Neo <sup>®</sup> with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata –A randomized, comparative, prospective study
- Treatment of alopecia areata: An Australian expert consensus statement
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- PUVA treatment of alopecia areata totalis and universalis: A retrospective study
- Treatment Effects of Intradermal Botulinum Toxin Type A Injection on Alopecia Areata
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Successful Treatment of Alopecia Areata with Topical Calcipotriol
- Treatment of pediatric alopecia areata: A systematic review
- Italian Guidelines in diagnosis and treatment of alopecia areata
- Treatment options for alopecia: an update, looking to the future
- Treatment strategies for alopecia
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Alopecia in Association with Malignancy: A Review
- Treatments for alopecia areata: A systematic review and network meta‐analysis
- Treatments options for alopecia
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies